Enhanced transcription of contractile 5-hydroxytryptamine 2A receptors via extracellular signal-regulated kinase 1/2 after organ culture of rat mesenteric artery

Basic and Clinical Pharmacology and Toxicology

Volumn 96, Issue 4, 2005, Pages 282-288

  Cao, Yong Xiao ^a,b   He, Lang Chong ^b   Xu, Cang Bao ^a,b   Luo, Guo Gang ^a,c   Edvinsson, Lars ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; KETANSERIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SB 386023; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; MALE; MEDIATOR RELEASE; MESENTERIC ARTERY; NERVE CONDUCTION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; KETANSERIN; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RNA, MESSENGER; SEROTONIN; TIME FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION; VASOCONSTRICTION;

EID: 15944408437     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto960402.x     Document Type: Article

References (28)

1. Arunlakshana, O. & H. O. Schild: Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 1959, 14, 48-58.
2. Banes, A., J. A. Florian & S. W. Watts: Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J. Pharmacol. Exp. Therap. 1999, 291, 1179-1187.
3. 1B receptors during development of DOCA-salt hypertension. BMC Pharmacol 2003, 3, 12-19.
4. Cheng, T. H., P. Y. Cheng, N. L. Shih, I. B. Chen, D. L Wang & J. J. Chen: Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Amer. Coll. Cardiol. 2003, 42, 1845-1854.
5. 2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin. Sci. 2003, 104, 241-245.
6. Elliott, J., Y. Berhane & S. R. Bailey: Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. Amer. J. Vet. Res. 2003, 64, 1124-1131.
7. Gul, H., O. Yildiz, A. Simsek, M. Balkan, N. Ersoz, S. Cetiner, A. Isimer & D. Sen: Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery. J. Cardiovasc. Pharmacol. 2003, 41, 307-315.
8. 1B receptor in cerebral arteries in rats. J. Neurosurg. 2003a, 99, 115-120.
9. Hansen-Schwartz J., H. N. Hoel, E. Nilsson, P. Tfelt-Hansen & L. Edvinsson: Endothelium-dependent relaxant responses to selective 5-HT(1B/1D) receptor agonists in the isolated middle cerebral artery of the rat. J. Vasc. Res. 2003b, 40, 561-566.
10. Henriksson, M., E. Stenman & L. Edvinsson: Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 2003, 34, 1479-1483.
11. Henriksson M., C. B. Xu & L. Edvinsson: Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Brit. J. Pharmacol. 2004, 142, 1155-1161.
12. Kihara H., K. Hirose, H. Koganei, N. Sasaki, H. Yamamoto, A. Kimura, T. Nishimori, M. Shoji & R. Yoshimoto: AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats. J. Cardiovasc. Pharmacol. 2000, 35, 523-530.
13. Lewis, T. S., P. S. Shapiro & N. G. Ahn: Signal transduction through MAP kinase cascades. Adv. Cancer. Res. 1998, 74, 49-139.
14. Moller, S., L. Edvinsson & M. Adner: Transcriptional regulated plasticity of vascular contractile endothelin ET(B) receptors after organ culture. Eur. J. Pharmacol. 1997, 329, 69-77.
15. Moller, S., E. Uddman, N. Welsh, L. Edvinsson & M. Adner: Analysis of the time course for organ culture-induced endothelin ET B receptor upregulation in rat mesenteric arteries. Eur. J. Pharmacol. 2002, 454, 209-215.
16. Ohnuki A. & Y. Ogawa: Differential modulation by the endothelium of contractile responses to 5-hydroxytryptamine, noradrenaline, and histamine in the rabbit isolated basilar artery. Gen. Pharmacol. 1997, 28, 681-687.
17. Pearce, W. J., J. M. Williams, M. M. Chang & W. T. Gerthoffer: ERK inhibition attenuates 5-HT-induced contractions in fetal and adult ovine carotid arteries. Arch. Physiol. Biochem. 2003, 111, 36-44.
18. Saini, H. K., N. Takeda, B. K. Goyal, H. Kumamoto, A. S. Arneja & N. S. Dhalla: Therapeutic potentials of sarpogrelate in cardiovascular disease. Cardiovasc. Drug. Rev. 2004, 22, 27-54.
19. Saltis, J., A. C. Thomas, A. Agrotis, J. H. Campbell, G. R. Campbell & A. Bobik: Expression of growth factor receptors in arterial smooth muscle cells. Dependency on cell phenotype and serum factors. Atherosclerosis 1995, 118, 77-87.
20. Tasaki, K., M. Hori, H. Ozaki, H. Karaki & I. Wakabayashi: Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions. J. Smooth Muscle Res. 2003, 39, 107-117.
21. 2+ signaling in the regulation of endothelial permeability. Vascul. Pharmacol. 2002, 39, 173-185.
22. Uddman, E., M. Adner & L. Edvinsson: Protein kinase C inhibitors decrease endothelin ET(B) receptor mRNA expression and contraction during organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2002, 452, 215-222.
23. Uddman, E., M. Henriksson, K. Eskesen & L. Edvinsson: Role of mitogen-activated protein kinases in endothelin ETB receptor upregulation after organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2003, 482, 39-47.
24. Verge, D. & A. Calas: Serotoninergic neurons and serotonin receptors: gains from cytochemical approaches. J. Chem. Neuroanat. 2000, 18, 41-56.
25. 2 receptor and its signaling pathway in aortic valve interstitial cells. Amer. J. Pathol. 2002, 161, 2209-2218.
26. Watts, S. W.: Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension 2002, 39, 825-829.
27. Yang, S. H., A. D. Sharrocks & A. J. Whitmarsh: Transcriptional regulation by the MAP kinase signaling cascades. Gene 2003, 320, 3-21.
28. Yue, T. L., J. L. Gu, C. Wang, A. D. Reith, J. C. Lee, R. C. Mirabile, R. Kreutz, Y. Wang, B. Maleeff, A. A. Parsons & E. H. Ohlstein: Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J. Biol. Chem. 2000, 275, 37895-37901.